Cargando…

mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of adult non-Hodgkin's lymphoma (NHL). While DLBCL is sensitive to chemotherapy, a certain percentage of patients with DLBCL experience relapse. Previous studies have indicated that Yiqichutan treatment, which was developed to tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Linzhu, Zhao, Yuanyuan, Liu, Zeyu, Wu, Jie, Lin, Lizhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401774/ https://www.ncbi.nlm.nih.gov/pubmed/32765691 http://dx.doi.org/10.3892/etm.2020.8940

Ejemplares similares

Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer
por: Li, Jiayin, et al.
Publicado: (2021)

Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas
por: Zhang, Cuifen, et al.
Publicado: (2021)

The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database
por: Zhang, Cuifen, et al.
Publicado: (2021)

Functional drug–target–disease network analysis of gene–phenotype connectivity for curcumin in hepatocellular carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2021)

The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
por: Ziel-Swier, Lotteke J. Y. M., et al.
Publicado: (2022)

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
por: Kluk, Michael J., et al.
Publicado: (2012)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022)

The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma
por: Voropaeva, Elena N., et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
por: Wawire, Jonathan, et al.
Publicado: (2019)

MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma
por: Qian, Chong-Sheng, et al.
Publicado: (2020)

Artificial intelligence to detect MYC translocation in slides of diffuse large B-cell lymphoma
por: Swiderska-Chadaj, Zaneta, et al.
Publicado: (2020)

Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019)

BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase
por: Zou, Dehui, et al.
Publicado: (2017)

New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma
por: Bigras, Gilbert, et al.
Publicado: (2018)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
por: Wang, Yanjie, et al.
Publicado: (2023)

Prognostic impact of miR-125b and miR-155b and their relationship with MYC and TP53 in diffuse large B-cell lymphoma: cell-of-origin classification matters
por: Filho, Eduardo Henrique Cunha Neves, et al.
Publicado: (2023)

MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
por: Gill, Kamraan Z., et al.
Publicado: (2014)

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit
por: Clipson, Alexandra, et al.
Publicado: (2015)

A digital method to interpret the C-MYC stain in diffuse large B cell lymphoma
por: Balakrishna, Jayalakshmi, et al.
Publicado: (2022)

MYC Negative Rectal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in an Immunocompetent Patient
por: Parikh, Jignesh G., et al.
Publicado: (2013)

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?
por: Asmar, Fazila, et al.
Publicado: (2014)

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells
por: Kong, Yuanyuan, et al.
Publicado: (2016)

hsa-miR-429 targets CBX8 to promote cell apoptosis in diffuse large B-cell lymphoma
por: Liang, Yan, et al.
Publicado: (2021)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis
por: Tao, Jiahao, et al.
Publicado: (2022)

miR-101 regulates cell proliferation and apoptosis by targeting KDM1A in diffuse large B cell lymphoma
por: Huang, Yiqun, et al.
Publicado: (2019)

Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
por: Aoki, Tomohiro, et al.
Publicado: (2016)

Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders
por: Kabasawa, Nobuyuki, et al.
Publicado: (2021)

Expression of IL‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma
por: Noyori, Osamu, et al.
Publicado: (2019)

Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis
por: Bellanger, Cynthia, et al.
Publicado: (2011)

MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B‐cell lymphoma
por: Kawamoto, Keisuke, et al.
Publicado: (2016)

MYC-Positive Diffuse Large B-Cell Lymphoma in Leukemic Phase at Presentation: A Diagnostic and Therapeutic Challenge
por: Bilgin, Yavuz Memis, et al.
Publicado: (2021)

Multifocal Extranodal Involvement of Diffuse Large B-Cell Lymphoma
por: Cabuk, Devrim, et al.
Publicado: (2013)

Diffuse large B cell lymphoma of the cervix with rectal involvement
por: Igwe, Elena, et al.
Publicado: (2014)

Diffuse Large B-cell Lymphoma Involving the Skeletal Muscle
por: Harada, Ko, et al.
Publicado: (2017)

Diffuse Large B Cell Lymphoma with Cutaneous and Gastrointestinal Involvement
por: Kyaw, Aye-Mya-Mya, et al.
Publicado: (2022)

Effects of 17-DMAG on diffuse large B-cell lymphoma cell apoptosis
por: Li, Jia-Jia, et al.
Publicado: (2017)

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
por: Fan, Qian, et al.
Publicado: (2016)

R-split-EPOCH plus high dose methotrexate in untreated diffuse large B cell lymphoma with MYC rearrangement or double expression of MYC and BCL-2
por: Sun, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aeu0pmrjm0s8h5f7f845fcloe1